分析两种雾化方案治疗支气管扩张的临床疗效(1)
[摘要] 目的 分析两种雾化方案治疗支气管扩张的临床疗效。 方法 选取我院2016年2月～2017年2月共50例支气管扩张患者作为研究对象，以随机分配为原则，分为观察组和对照组各25例。对照组通过沐舒坦雾化方案治疗，观察组通过沐舒坦联合万托林、普米克令舒雾化方案进行治疗，对比两组患者的临床疗效。 结果 观察组患者咳嗽缓解时间、住院时间、SAS评分、SDS评分低于对照组患者，差异有统计学意义(P<0.05)；观察组患者肺功能、总有效率高于对照组患者，差异有统计学意义(P<0.05)。 结论 沐舒坦联合万托林、普米克令舒治疗支气管扩张具有良好的临床疗效，能有效改善患者的肺功能，促进患者康复，值得在临床推广应用。
[关键词] 雾化；支气管扩张；治疗；疗效
[中图分类号] R562.22 [文献标识码] A [文章编号] 2095-0616(2017)11-236-03
Analysis on clinical curative effects of two nebulization schemes in treatment of bronchiectasis
LI Qian ZHANG Hengzhong LIU Lijun CHEN Minya ZHANG Wei
Department of Respiration，the First People’s Hospital of Baiyin，Baiyin 730900，China
[Abstract] Objective To analyze clinical curative effects of two nebulization schemes in treatment of bronchiectasis. Methods 50 patients with bronchiectasis in our hospital from February 2016 to February 2017 were selected as research objects and they were divided into the observation group and the control group，with 25 in each according to random allocation principle.The control group was given mucosolvan nebulization scheme for treatment while the observation group was treated by nebulization scheme of mucosolvan，ventolin and pulmicort respules.Clinical curative effects of patients in two groups were compared. Results Time for relieving cough， hospital stay，SAS score，SDS score of patients in the observation group were lower than those of the control group.The difference was significant (P<0.05) and there was statistical significance.Pulmonary function and total effective rate of patients in the observation group were higher than those of the control group.The difference was significant (P<0.05) and there was statistical significance. Conclusion Mucosolvan，ventolin and pulmicort respules in treatment of bronchiectasis has a good clinical curative effect.It can effectively improve ulmonary function of patients and promote rehabilitation，which is worthy of clinical promotion and application.
[Key words] Nebulization；Bronchiectasis；Treatment；Curative effect
支氣管扩张常发生于住院患者，多数由于呼吸道感染、支气管阻塞等引起。患者大多存在生理虚弱，营养不均衡，对于急性发作患者，可能出现黏液分泌过度，痰量增加[1]。同时，该病症会使患者出现气喘、液体丢失致痰液粘稠，不易咳出，排痰难度加大，黏液滞留也会对细菌聚集造成影响，最终引发肺炎[2]。本次研究采用沐舒坦联合万托林、普米克令舒雾化方案进行治疗，取得了良好的成果。现报道如下。
1 资料与方法
1.1 一般资料
选取我院2016年2月～2017年2月共50例支气管扩张患者作为研究对象。纳入标准：符合相关医学调理中固定的支气管扩张标准；具有气促、咳脓痰、咳嗽及肺部湿啰音的症状。排除标准：不符合上述标准的患者，中途脱落病例。以随机分配为原则，分为观察组和对照组各25例。观察组中男14例，女11例，年龄31～64岁，平均(43.7±9.2)岁，病程2～19年，平均(8.4±7.2)年；对照组中男13例，女12例，年龄30～66岁，平均(41.4±8.5)岁，病程3～20年，平均病程(8.0±7.6)年。所有患者均对研究情况知情，签署知情同意书。两组患者在性别、年龄、病程等基本资料方面差异无统计学意义(P>0.05)，具有可比性。, 百拇医药(李倩?张衡中?刘丽君?陈敏亚?张玮)
[关键词] 雾化；支气管扩张；治疗；疗效
[中图分类号] R562.22 [文献标识码] A [文章编号] 2095-0616(2017)11-236-03
Analysis on clinical curative effects of two nebulization schemes in treatment of bronchiectasis
LI Qian ZHANG Hengzhong LIU Lijun CHEN Minya ZHANG Wei
Department of Respiration，the First People’s Hospital of Baiyin，Baiyin 730900，China
[Abstract] Objective To analyze clinical curative effects of two nebulization schemes in treatment of bronchiectasis. Methods 50 patients with bronchiectasis in our hospital from February 2016 to February 2017 were selected as research objects and they were divided into the observation group and the control group，with 25 in each according to random allocation principle.The control group was given mucosolvan nebulization scheme for treatment while the observation group was treated by nebulization scheme of mucosolvan，ventolin and pulmicort respules.Clinical curative effects of patients in two groups were compared. Results Time for relieving cough， hospital stay，SAS score，SDS score of patients in the observation group were lower than those of the control group.The difference was significant (P<0.05) and there was statistical significance.Pulmonary function and total effective rate of patients in the observation group were higher than those of the control group.The difference was significant (P<0.05) and there was statistical significance. Conclusion Mucosolvan，ventolin and pulmicort respules in treatment of bronchiectasis has a good clinical curative effect.It can effectively improve ulmonary function of patients and promote rehabilitation，which is worthy of clinical promotion and application.
[Key words] Nebulization；Bronchiectasis；Treatment；Curative effect
支氣管扩张常发生于住院患者，多数由于呼吸道感染、支气管阻塞等引起。患者大多存在生理虚弱，营养不均衡，对于急性发作患者，可能出现黏液分泌过度，痰量增加[1]。同时，该病症会使患者出现气喘、液体丢失致痰液粘稠，不易咳出，排痰难度加大，黏液滞留也会对细菌聚集造成影响，最终引发肺炎[2]。本次研究采用沐舒坦联合万托林、普米克令舒雾化方案进行治疗，取得了良好的成果。现报道如下。
1 资料与方法
1.1 一般资料
选取我院2016年2月～2017年2月共50例支气管扩张患者作为研究对象。纳入标准：符合相关医学调理中固定的支气管扩张标准；具有气促、咳脓痰、咳嗽及肺部湿啰音的症状。排除标准：不符合上述标准的患者，中途脱落病例。以随机分配为原则，分为观察组和对照组各25例。观察组中男14例，女11例，年龄31～64岁，平均(43.7±9.2)岁，病程2～19年，平均(8.4±7.2)年；对照组中男13例，女12例，年龄30～66岁，平均(41.4±8.5)岁，病程3～20年，平均病程(8.0±7.6)年。所有患者均对研究情况知情，签署知情同意书。两组患者在性别、年龄、病程等基本资料方面差异无统计学意义(P>0.05)，具有可比性。, 百拇医药(李倩?张衡中?刘丽君?陈敏亚?张玮)